CytoSorbents is a therapeutic device company focused on critical care. The company uses blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. CytoSorbents’ purification technology is based on biocompatible, highly porous polymer beads that are able to actively remove toxic substances from blood and other bodily fluids by pore capture and adsorption. The company’s flagship product, CytoSorb, is approved in the European Union as a safe and effective cytokine filter. For more information, visit the company’s Web site at www.cytosorbents.com.

The 6th Annual OneMedForum is a gathering of leading investors and management of some of the most promising emerging life science companies in Asia and North America. Through panels, workshops and up-close programming with top industry leaders, attendees explore strategies for company growth finance with healthcare investors looking for outsized returns. For more information, please visit www.onemedforum.com.

Let us hear your thoughts below: